Summary: In a split decision, the U.S. Court of Appeals for the Federal Circuit affirmed…
US FDA Grants Orphan Drug Designation to Gracell’s FasTCAR-enabled BCMA/CD19 dual-targeting CAR-T cell therapy, GC012F to Treat Multiple Myeloma.
Synopsis: The FDA granted orphan drug designation to GC012F, a novel chimeric antigen receptor T-cell…
The European Commission Grants Marketing Authorization for VUMERITY® (Diroximel Fumarate) as Oral Treatment for Relapsing-Remitting Multiple Sclerosis.
SYNOPSIS: VUMERITY is a next-generation oral fumarate treatment for people with relapsing-remitting MS with established…
SECARNA AND ACHILLES
Secarna Pharmaceuticals and Achilles Therapeutics sign Multiple Agreement to Develop Optimized T cell Therapies
Secarna to receive an upfront along with an option exercise fees & is also eligible…
ANI Pharmaceuticals Announced the FDA Approval of Purified Cortrophin™ Gel for Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis and Nephrotic Syndrome.
KEY POINTS: The U.S. Food and Drug Administration (FDA) has approved the Company’s supplemental New…
Keypoints Albaugh announced the EPA registration of Anchor™ 3L ST in multiple crop segments as…
Active Pharmaceutical Ingredients (API)Lenalidomide
Keypoints Dr. Reddy’s Laboratories said it has received approval from the US health regulator to…